Lantern Pharma Inc (LTRN)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -767.111 | -257.886 | -54.219 | -26.218 | -21.478 | -31.15 |
Return on Equity (%) | 1708.911 | -655.331 | -57.243 | -27.091 | -22.35 | -32.93 |
Return on Invested Capital (%) | 1708.911 | -882.909 | -57.755 | -27.902 | -22.806 | -36.899 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.178 | 0.829 | 3.167 | 6.454 | 5.161 | 3.764 |
Earnings Per Share | -1.518 | -2.135 | -0.95 | -1.115 | -1.313 | -1.469 |
Cash Per Share | 0.391 | 1.084 | 3.091 | 4.646 | 3.427 | 2.018 |
Working Capital Per Share | -0.182 | 0.653 | 3.164 | 6.348 | 5.151 | 3.741 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.518 | -2.135 | -0.95 | -1.115 | -1.313 | -1.469 |
EBITDA Per Share | -1.518 | -2.135 | -0.95 | -1.115 | -1.313 | -1.469 |
Free Cash Flow Per Share | -1.518 | -2.132 | -0.948 | -1.114 | -1.312 | -1.468 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 1,14M | 1,14M | 6,22M | 11,09M | 10,86M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 10,86M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 34,26M |
Ratio cours/bénéfice | -2,11 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,54 |
Ratio prix/valeur comptable | 0,83 |
Rendement de dividende | - |
Actions en circulation | 10,78M |
Volume moyen (1 semaine) | 68,49k |
Volume moyen (1 mois) | 81,1k |
Variation sur 52 semaines | -21,50% |
Plus haut sur 52 semaines | 11,99 |
Plus bas sur 52 semaines | 2,79 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales